Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by GEORGE J CHANG and BRIAN KEITH BEDNARSKI.
GEORGE J CHANG
Connection Strength
6.019
BRIAN KEITH BEDNARSKI
  1. MDT-How it is important in rectal cancer. Abdom Radiol (NY). 2023 09; 48(9):2807-2813.
    View in: PubMed
    Score: 0.907
  2. Assessment of Ileostomy Output Using Telemedicine: A Feasibility Trial. Dis Colon Rectum. 2018 Jan; 61(1):77-83.
    View in: PubMed
    Score: 0.620
  3. The prognostic impact of tumor deposits in colorectal cancer: More than just N1c. Cancer. 2024 Dec 01; 130(23):4052-4060.
    View in: PubMed
    Score: 0.247
  4. The Learning Curve for Robotic Lateral Pelvic Lymph Node Dissection for Rectal Cancer: A View From the West. Dis Colon Rectum. 2024 Oct 01; 67(10):1281-1290.
    View in: PubMed
    Score: 0.243
  5. Perioperative and oncological outcomes following robotic en bloc multivisceral resection for colorectal cancer. Colorectal Dis. 2024 May; 26(5):949-957.
    View in: PubMed
    Score: 0.239
  6. Magnetic Resonance Imaging Directed Surgical Decision Making for Lateral Pelvic Lymph Node Dissection in Rectal Cancer After Total Neoadjuvant Therapy (TNT). Ann Surg. 2022 10 01; 276(4):654-664.
    View in: PubMed
    Score: 0.212
  7. What is the Risk for Peritoneal Metastases and Survival Afterwards in T4 Colon Cancers? Ann Surg Oncol. 2022 Mar 19.
    View in: PubMed
    Score: 0.208
  8. Prognosis for Poorly Differentiated, High-Grade Rectal Neuroendocrine Carcinomas. Ann Surg Oncol. 2022 Apr; 29(4):2539-2548.
    View in: PubMed
    Score: 0.203
  9. Development of an Online Curriculum for Surgeons on the Use of Pelvic Magnetic Resonance Imaging in Rectal Cancer and Results of a Pilot Study. J Surg Res. 2022 02; 270:279-285.
    View in: PubMed
    Score: 0.202
  10. High Rate of Positive Circumferential Resection Margin in Colon Cancer: A National Appraisal and Call for Action. Ann Surg. 2022 12 01; 276(6):1023-1028.
    View in: PubMed
    Score: 0.190
  11. Residents entering Complex General Surgical Oncology fellowship lack confidence with pelvic MRI for rectal cancer: Results of a needs assessment survey. Am J Surg. 2020 02; 219(2):304-308.
    View in: PubMed
    Score: 0.176
  12. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation? Dis Colon Rectum. 2019 10; 62(10):1158-1166.
    View in: PubMed
    Score: 0.175
  13. Robotic Lateral Pelvic Lymph Node Dissection after Neoadjuvant Chemoradiation: View from the West. Dis Colon Rectum. 2018 09; 61(9):1119-1120.
    View in: PubMed
    Score: 0.162
  14. Oncological Outcomes After Robotic Proctectomy for Rectal Cancer: Analysis of a Prospective Database. Ann Surg. 2018 03; 267(3):521-526.
    View in: PubMed
    Score: 0.157
  15. Accelerated enhanced Recovery following Minimally Invasive colorectal cancer surgery (RecoverMI): a study protocol for a novel randomised controlled trial. BMJ Open. 2017 Jul 20; 7(7):e015960.
    View in: PubMed
    Score: 0.150
  16. Impact of Recurrence and Salvage Surgery on Survival After Multidisciplinary Treatment of Rectal Cancer. J Clin Oncol. 2017 Aug 10; 35(23):2631-2638.
    View in: PubMed
    Score: 0.150
  17. Three Different Approaches to the Inferior Mesenteric Artery during Robotic D3 Lymphadenectomy for Rectal Cancer. Ann Surg Oncol. 2017 Jul; 24(7):1923.
    View in: PubMed
    Score: 0.146
  18. Oncologic Outcomes of Extended Robotic Resection for Rectal Cancer. Ann Surg Oncol. 2016 07; 23(7):2249-57.
    View in: PubMed
    Score: 0.136
  19. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg. 2015 Jan; 150(1):17-22.
    View in: PubMed
    Score: 0.126
  20. Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. J Clin Oncol. 2014 Sep 20; 32(27):2967-74.
    View in: PubMed
    Score: 0.123
  21. Early Postoperative Prediction of Complications and Readmission After Colorectal Cancer Surgery Using an Artificial Neural Network. Dis Colon Rectum. 2024 Oct 01; 67(10):1341-1352.
    View in: PubMed
    Score: 0.061
  22. Para-aortic Lymph Node Dissection for Colorectal Cancer: Predicting Pathologic Lymph Node Positivity and Optimizing Outcomes. Ann Surg Oncol. 2024 Sep; 31(9):5962-5970.
    View in: PubMed
    Score: 0.060
  23. Total Neoadjuvant Therapy for Rectal Cancer: Which Regimens to Use? Cancers (Basel). 2024 May 31; 16(11).
    View in: PubMed
    Score: 0.060
  24. The current multidisciplinary management of rectal cancer. Ann Gastroenterol Surg. 2024 May; 8(3):394-400.
    View in: PubMed
    Score: 0.059
  25. Endoscopic and imaging outcomes of PD-1 therapy in localised dMMR colorectal cancer. Eur J Cancer. 2023 11; 194:113356.
    View in: PubMed
    Score: 0.058
  26. Therapeutic lateral pelvic lymph node dissection in rectal cancer: when to dissect? Size is not everything. Br J Surg. 2023 07 17; 110(8):985-986.
    View in: PubMed
    Score: 0.057
  27. Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer. Cancers (Basel). 2023 Mar 10; 15(6).
    View in: PubMed
    Score: 0.056
  28. Impact of cumulative operative time on postoperative complication risk in simultaneous resections of colorectal liver metastases and primary tumors. HPB (Oxford). 2023 03; 25(3):347-352.
    View in: PubMed
    Score: 0.055
  29. Treatment strategies for locally recurrent rectal cancer. Eur J Surg Oncol. 2022 11; 48(11):2292-2298.
    View in: PubMed
    Score: 0.052
  30. Adoption of Telemedicine for Postoperative Follow-Up After Inpatient Cancer-Related Surgery. JCO Oncol Pract. 2022 07; 18(7):e1091-e1099.
    View in: PubMed
    Score: 0.052
  31. Germline Cancer Risk Profiles of Patients With Young-Onset Colorectal Cancer: Findings From a Prospective Universal Germline Testing and Telegenetics Program. Dis Colon Rectum. 2023 04 01; 66(4):531-542.
    View in: PubMed
    Score: 0.052
  32. Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution. Oncologist. 2022 02 03; 27(1):40-47.
    View in: PubMed
    Score: 0.051
  33. Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal Cancer. Clin Colorectal Cancer. 2022 03; 21(1):e28-e37.
    View in: PubMed
    Score: 0.050
  34. Colorectal cancer during pregnancy or postpartum: Case series and literature review. Obstet Med. 2022 Jun; 15(2):118-124.
    View in: PubMed
    Score: 0.050
  35. Is neoadjuvant therapy an alternative strategy to immediate surgery in locally perforated colon cancer? Colorectal Dis. 2021 12; 23(12):3162-3172.
    View in: PubMed
    Score: 0.050
  36. Quality and Location of the Surgical Episode Mediate a Large Proportion of Socioeconomic-Based Survival Disparities in Patients with Resected Stage I-III Colon Cancer. Ann Surg Oncol. 2022 Jan; 29(1):706-716.
    View in: PubMed
    Score: 0.050
  37. Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study. Eur J Surg Oncol. 2021 09; 47(9):2441-2449.
    View in: PubMed
    Score: 0.049
  38. CEA as a blood-based biomarker in anal cancer. Oncotarget. 2021 May 25; 12(11):1037-1045.
    View in: PubMed
    Score: 0.049
  39. The Pelvis-First Approach for Robotic Proctectomy in Patients with Redundant Abdominal Colon. Ann Surg Oncol. 2019 Aug; 26(8):2514-2515.
    View in: PubMed
    Score: 0.043
  40. Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine. Dis Colon Rectum. 2019 04; 62(4):429-437.
    View in: PubMed
    Score: 0.042
  41. Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation. Adv Radiat Oncol. 2018 Oct-Dec; 3(4):595-600.
    View in: PubMed
    Score: 0.040
  42. Hyperfractionated Accelerated Reirradiation for Patients With Recurrent Anal Cancer Previously Treated With Definitive Chemoradiation. Am J Clin Oncol. 2018 07; 41(7):632-637.
    View in: PubMed
    Score: 0.040
  43. Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinoma. J Gastrointest Oncol. 2017 Dec; 8(6):990-997.
    View in: PubMed
    Score: 0.039
  44. Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity. Radiother Oncol. 2017 01; 122(1):146-151.
    View in: PubMed
    Score: 0.036
  45. DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics. J Clin Oncol. 2016 09 01; 34(25):3039-46.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.